ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q2 2014. The put-call ratio across all filers is 13.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $296,758 | -9.8% | 72,380 | -21.5% | 0.00% | – |
| Q4 2021 | $329,000 | -2.4% | 92,174 | -0.4% | 0.00% | – |
| Q3 2021 | $337,000 | -21.3% | 92,547 | -5.8% | 0.00% | – |
| Q2 2021 | $428,000 | +8.1% | 98,261 | +1.9% | 0.00% | – |
| Q1 2021 | $396,000 | -0.8% | 96,448 | -3.5% | 0.00% | – |
| Q4 2020 | $399,000 | +47.8% | 99,992 | -0.1% | 0.00% | – |
| Q3 2020 | $270,000 | +0.4% | 100,130 | 0.0% | 0.00% | – |
| Q2 2020 | $269,000 | +8.5% | 100,130 | -4.5% | 0.00% | – |
| Q1 2020 | $248,000 | -46.3% | 104,883 | +6.7% | 0.00% | – |
| Q4 2019 | $462,000 | +29.1% | 98,300 | -5.2% | 0.00% | – |
| Q3 2019 | $358,000 | +4.7% | 103,643 | -0.4% | 0.00% | – |
| Q2 2019 | $342,000 | +15.9% | 104,068 | +7.0% | 0.00% | – |
| Q1 2019 | $295,000 | +4.6% | 97,234 | -6.5% | 0.00% | – |
| Q4 2018 | $282,000 | +89.3% | 104,012 | +133.8% | 0.00% | – |
| Q3 2018 | $149,000 | -51.3% | 44,487 | -62.5% | 0.00% | – |
| Q2 2018 | $306,000 | +19.5% | 118,707 | +2.4% | 0.00% | – |
| Q1 2018 | $256,000 | +8.0% | 115,943 | -2.4% | 0.00% | – |
| Q4 2017 | $237,000 | -39.1% | 118,846 | -0.9% | 0.00% | – |
| Q3 2017 | $389,000 | -0.8% | 119,903 | -1.4% | 0.00% | – |
| Q2 2017 | $392,000 | +1351.9% | 121,633 | +1188.2% | 0.00% | – |
| Q1 2017 | $27,000 | +800.0% | 9,442 | +717.5% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 1,155 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 1,155 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -98.9% | 1,155 | -98.9% | 0.00% | – |
| Q1 2016 | $92,000 | -27.0% | 107,361 | +2.8% | 0.00% | – |
| Q4 2015 | $126,000 | -28.8% | 104,390 | +0.3% | 0.00% | – |
| Q3 2015 | $177,000 | -16.9% | 104,090 | +2.0% | 0.00% | – |
| Q2 2015 | $213,000 | -5.3% | 102,062 | +22.7% | 0.00% | – |
| Q1 2015 | $225,000 | +9.2% | 83,189 | +3.9% | 0.00% | – |
| Q4 2014 | $206,000 | +40.1% | 80,084 | -0.6% | 0.00% | – |
| Q3 2014 | $147,000 | -29.0% | 80,568 | +4.0% | 0.00% | – |
| Q2 2014 | $207,000 | -33.0% | 77,498 | -12.2% | 0.00% | – |
| Q1 2014 | $309,000 | -22.6% | 88,254 | -0.9% | 0.00% | -100.0% |
| Q4 2013 | $399,000 | +5.8% | 89,039 | -4.3% | 0.00% | 0.0% |
| Q3 2013 | $377,000 | -6.0% | 92,997 | -3.5% | 0.00% | 0.0% |
| Q2 2013 | $401,000 | – | 96,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |